CoChat

Role of extracellular signal–regulated kinase pathway in RRR‐α‐tocopheryl succinate–induced differentiation of human MDA‐MB‐435 breast cancer cells

You, Huihong, Yu, Weiping, Munoz‐Medellin, Debbie, Brown, Powel H., Sanders, Bob G., Kline, Kimberly · 2002 · Molecular Carcinogenesis
Cited by 39

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

RRR‐α‐tocopheryl succinate (vitamin E succinate, VES) induces differentiation of human breast cancer cells. Previous studies ruled out transforming growth factor‐β and c‐jun N‐terminal kinase involvement in VES‐induced differentiation but implicated extracellular signal–regulated kinases (ERKs). Here we show that dominant‐negative mutants of either mitogen‐activated protein kinase kinase (MEK) 1 or ERK1 blocked VES‐induced differentiation of MDA‐MB‐435 cells, as measured by induction of cytokeratin 18 and p21 (Waf1/Cip1) proteins. Blockage of c‐jun protein expression using c‐jun antisense oligonucleotides or expression of an inducible dominant‐negative c‐jun mutant protein inhibited VES‐induced differentiation. Elevated expression of wild‐type c‐jun alone was sufficient to induce cellular differentiation. A role for p21 (Waf1/Cip1) is implicated, in that p21 antisense oligomers blocked VES‐induced differentiation. In summary, MEK1, ERK1, the transcription factor c‐jun, and the cyclin‐dependent kinase inhibitor p21 (Waf1/Cip1) play a part in VES‐induced differentiation of human MDA‐MB‐435 breast cancer cells. © 2002 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mc.10040

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 39

Metadata

Authors
You, H., Yu, W., Munoz‐Medellin, D., Brown, P. H., Sanders, B. G., & Kline, K.
Venue
Molecular Carcinogenesis
Publisher
Wiley
Published
2002-03-25
Volume
33
Issue
4
Pages
228-236
ISSN
  • 0899-1987 (ISSN-L)
  • 1098-2744
OpenAlex
W2077625194
Cited by
39
References
2
FWCI
2.27
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.